STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease
STAT
DECEMBER 12, 2023
These drugs have price tags of $2.2 The news comes as researchers are still processing the Food and Drug Administration’s landmark approval of two cutting-edge sickle cell therapies, one made by Vertex Pharmaceuticals and CRISPR Therapeutics and the other by Bluebird Bio. million and $3.1 million, respectively.
Let's personalize your content